Delivery Order SPE2DX22D0010-SPE2D826FCF07
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $141,800.40 delivery order to AmerSourceBergen Drug Corp on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price contract, which carries no set-aside designation, is a child order under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The delivery order will be performed at...
- On January 7, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a $111,228 delivery order (Contract No. 4570419917) to AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., headquartered in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order is not set aside for any specific business category and has an ultimate completion date of January 8, 2026. The contract represents a task order under AmerSourceBergen's existing Indefinite Delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,189.08 to AmerSourceBergen Drug Corp on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order is a child contract executed under AmerSourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The award was made without a set-aside...
- The Department of Defense Medical Supply Chain awarded a delivery order valued at $160,252.80 to AmerSourceBergen Drug Corp (CAGE 0U9U0) on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order was awarded on a non-set-aside, competitive basis to support federal medical procurement needs. The award represents a task order under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the Defense Logistics...
- This delivery order, awarded January 7, 2026, to AmerSourceBergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency Medical Supply Chain, represents a $15,514.03 firm fixed-price contract with an ultimate completion date of January 8, 2026. The award is not set-aside and was competitively awarded. AmerSourceBergen will perform this contract at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery...
- The U.S. Department of Defense Medical Supply Chain awarded a $44,491.20 firm fixed-price delivery order to AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., on January 6, 2026, with completion targeted for January 7, 2026. This non-competitive delivery order was issued under AmerSourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999.9 million through December 2026. The contract utilizes this comprehensive...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,293.60 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., on January 6, 2026. This firm fixed-price, competitively awarded delivery order is scheduled for completion by January 7, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerSourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,472.63 to AmerSourceBergen Drug Corp on January 7, 2026, for pharmaceutical products and medical supplies to support federal healthcare operations. The award is a non-set-aside, competitively awarded delivery order under a firm fixed-price contract structure, with performance scheduled for completion by January 8, 2026. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a $31,536.30 delivery order to AmerSourceBergen Drug Corp on January 7, 2026, for pharmaceutical products and medical supplies supporting federal healthcare systems. This firm fixed-price, competitively awarded delivery order is scheduled for completion by January 29, 2026, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerSourceBergen's parent...
- AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $3,040.24 by the Defense Logistics Agency's Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 8, 2026. This non-set-aside, competitively awarded contract represents a child delivery order under a larger indefinite delivery contract vehicle. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania....
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCF07Delivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a $5,204.76 firm fixed-price delivery order to AmerSourceBergen Drug Corp (CAGE 0U9U0) on January 6, 2026, with an ultimate completion date of January 7, 2026. This is a non-set-aside, competitively awarded contract with performance occurring in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerSourceBergen), a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement. This delivery order represents a task order executed under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The prime indefinite delivery vehicle enables the company to supply comprehensive pharmaceutical products and medical commodities, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare supplies across multiple therapeutic domains to support military healthcare programs globally. The company's contract portfolio demonstrates extensive experience fulfilling federal medical supply requirements through competitive procurement channels.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 1/5/26 |